Jasmina I. Ivanova

Vice President

Jasmina I. Ivanova

New York

Education

M.A., economics, Duke University; B.A., economics and French, Davidson College

Summary of Experience

Ms. Ivanova specializes in health outcomes research. Her areas of expertise include retrospective claims analysis, survey development, chart review studies, cost-effectiveness and quality-of-life studies using clinical trial data, and health outcomes research with advanced statistical methods. Her work has included comparative analyses of outcomes, direct health care costs, and indirect work-loss costs of alternative therapies across many conditions; burden-of-illness studies; survey development to assess patients' experience with treatment or physician decision making; medication adherence and outcomes studies; survival analyses to assess the effectiveness of different therapies; and cost-effectiveness and quality-of-life analyses based on clinical trial data. Recently, she has led multiple physician survey and chart review studies and patient survey studies on cardiovascular disease, diabetes, chronic pain, and oncology. Ms. Ivanova has also undertaken health care strategy engagements, provided litigation support in antitrust matters involving major software and pharmaceutical companies, and assisted with the analyses in a large mutual fund fee remediation case. Ms. Ivanova has published numerous articles in peer-reviewed clinical and health outcomes journals.

Selected Publishing

  • Glioblastoma treatment patterns, survival, and healthcare resource use in real-world clinical practice in the USA

    Drugs Context. 2015 Mar 10;4. pii: 212274
    2015

    Girvan AC, Carter GC, Li L, Kaltenboeck A, Ivanova J, Koh M, Stevens J, Hayes-Larson E, Lahn MM

      View abstract
    Health Care
  • Duloxetine use in employees with low back pain: treatment patterns and direct and indirect costs

    Pain Med. 2014 Jun;15(6):1015-26
    2014

    Ivanova JI, Birnbaum HG, Kantor E, Schiller M, Swindle RW.

      View abstract
    Health Care
  • Retrospective Analysis of Dose Titration and Serum Testosterone Level Assessments in Patients Treated With Topical Testosterone

    Am J Mens Health. 2014 Sep 30. pii: 1557988314551569
    2014

    Muram D, Kaltenboeck A, Boytsov N, Hayes-Larson E, Ivanova J, Birnbaum HG, Swindle R

      View abrstact
    Health Care
  • Healthcare resource use and costs of privately insured patients who switch, discontinue, or persist on anti-muscarinic therapy for overactive bladder

    J Med Econ. 2014 Oct;17(10):741-50
    2014

    Ivanova JI, Hayes-Larson E, Sorg RA, Birnbaum HG, Berner T.

      View abstract
    Health Care
  • The prevalence and economic impact of prescription opioid-related side effects among patients with chronic noncancer pain

    J Opioid Manag. 2013 Jul-Aug;9(4):239-54
    2013

    Ivanova JI, Birnbaum HG, Yushkina Y, Sorg RA, Reed J, Merchant S.

      View abstract
    Health Care
  • Evaluating the utility of existing patient-reported outcome scales in novel patient populations with pancreatic cancer, lung cancer, and myeloproliferative neoplasms using medicare current beneficiary survey data

    Patient. 2013; 6(3):189-200
    2013

    Ivanova JI, Mytelka DS, Duh MS, Birnbaum HG, Cummings AK, San Roman AM, Price GL, Swindle RW

      View abstract
    Health Care
  • Costs Associated with Intravenous Cancer Therapy Administration in Patients with Metastatic Soft Tissue Sarcoma in a US Population

    Sarcoma. 2013;2013:947413
    2013

    Duh MS, Hackshaw MD, Ivanova JI, Kruse G, Miller LA, Lefebvre P, Karner P, Wong B

      View abstract
    Health Care
  • Real-world role of tricyclic antidepressants in the treatment of fibromyalgia

    Pain Pract. 2012 Jan 9.
    2012

    Reed C, Birnbaum H, Ivanova J, Schiller M, Waldman T, Mullen R, Swindle R

      View abstract
    Health Care
  • Direct and indirect costs associated with Dupuytren's contracture

    J Med Econ. 2012;15(4):664-71. Epub 2012 Mar 21.
    2012

    Macaulay D, Ivanova J, Birnbaum H, Sorg R, Skodny P

      View abstract
    Health Care
  • The direct and indirect costs among U.S. privately insured employees with hypogonadism

    J Sex Med. 2012 Sep;9(9):2438-47
    2012

    Kaltenboeck A, Foster S, Ivanova J, Diener M, Bergman R, Birnbaum H, Kinchen K, Swindle R

      View abstract
    Health Care
  • Impact of medication adherence to disease-modifying drugs on severe relapse, and direct and indirect costs among employees with multiple sclerosis in U.S.

    J Med Econ. 2012;15(3):601-9
    2012

    Ivanova J, Bergman R, Birnbaum H, Phillips A, Stewart M, Meletiche D

      View abstract
    Health Care
  • Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma

    J Allergy Clin Immunol. 2012 May;129(5):1229-35
    2012

    Ivanova J, Bergman R, Birnbaum H, Colice G, Silverman R, McLaurin K

      View abstract
    Health Care
  • Duloxetine use in chronic low back pain: treatment patterns and costs

    Pharmacoeconomics. 2012 Jul 1;30(7):595-609
    2012

    Ivanova J, Birnbaum H, Kantor E, Schiller M, Swindle R

      View abstract
    Health Care
  • Cost of post-traumatic stress disorder vs major depressive disorder among patients covered by medicaid or private insurance

    Am J Manag Care. 2011 Aug 1;17(8):e314-23.
    2011

    Ivanova J, Birnbaum H, Chen L, Duhig A, Dayoub E, Kantor E, Schiller M, Phillips G

      View abstract
    Health Care
  • Excess costs associated with patients with chronic thromboembolic pulmonary hypertension in a U.S. privately insured population

    Appl Health Econ Health Policy. 2011 Nov 1;9(6):377-87.
    2011

    Kirson N, Birnbaum H, Ivanova J, Waldman T, Joish V, Williamson T

      View abstract
    Health Care
  • Excess costs associated with patients with pulmonary arterial hypertension in a U.S. privately insured population

    Appl Health Econ Health Policy. 2011 Sep 1;9(5):293-303.
    2011

    Kirson N, Birnbaum H, Ivanova J, Waldman T, Joish V, Williamson T

      View abstract
    Health Care
  • Physicians' decisions to prescribe antidepressant therapy in older patients with depression in a U.S. managed care plan

    Drugs Aging. 2011 Jan 1;28(1):51-62
    2011

    Ivanova J, Bienfait-Beuzon C, Birnbaum H, Connolly C, Emani S, Sheehy M

      View abstract
    Health Care
  • Prevalence of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the United States

    Curr Med Res Opin. 2011 Sep;27(9):1763-8.
    2011

    Kirson N, Birnbaum H, Ivanova J, Waldman T, Joish V, Williamson T

      View abstract
    Health Care
  • Real-world practice patterns, health-care utilization, and costs in patients with low back pain: the long road to guideline-concordant care

    Spine J. 2011 Jul;11(7):622-32
    2011

    Ivanova J, Birnbaum H, Schiller M, Kantor E, Johnstone B, Swindle R

      View abstract
    Health Care
  • Economic Burden of Epilepsy among the Privately Insured in the US

    PharmacoEconomics, Volume 28, Number 8, 1 August 2010, pp. 675-685(11)
    2010

    Ivanova JBirnbaum H, Kidolezi Y, Qiu Y, Mallett D, Caleo S

      View abstract
    Health Care
  • Direct and indirect costs associated with epileptic partial onset seizures among the privately insured in the United States

    Epilepsia, 2010;51(5):838-44
    2010

    Ivanova JBirnbaum H, Kidolezi Y, Qiu Y, Mallett D, Caleo S

      View abstract
    Health Care
  • Comparing healthcare costs of Medicaid patients with postherpetic neuralgia (PHN) treated with lidocaine patch 5 percent versus gabapentin or pregabalin

    J Med Econ. 2010 Sep;13(3):482-91
    2010

    Kirson NIvanova JBirnbaum H, Kantor E, Puenpatom R, Ben-Joseph R, Summers K

      View abstract
    Health Care
  • Direct and indirect costs of employees with treatment-resistant and non-treatment-resistant major depressive disorder

    Curr Med Res Opin. 2010 Oct;26(10):2475-84
    2010

    Ivanova JBirnbaum H, Kidolezi Y,  Subramanian G, Khan S, Stensland M

      View abstract
    Health Care
  • Cardiovascular and Economic Outcomes After Initiation of Atorvastatin versus Simvastatin in an Employed Population Stratified by Cardiovascular Risk

    Am J Ther. 2010 Aug 27
    2010

    Simpson R Jr, Signorovitch J, Ramakrishnan K, Ivanova JBirnbaum H, Kuznik A

      View abstract
    Epidemiology & BiostatisticsHealth Care
  • Descriptive analysis of Medicaid patients with postherpetic neuralgia treated with lidocaine patch 5 percent

    J Med Econ. 2010 Sep;13(3):472-81
    2010

    Kirson NIvanova JBirnbaum H, Kantor E, Amy Puenpatom R, Ben-Joseph R, Summers K

      View abstract
    Epidemiology & BiostatisticsHealth Care
  • The cost of disability and medically related absenteeism among employees with multiple sclerosis in the US

    Pharmacoeconomics
    2009

    Ivanova JIBirnbaum HG, Samuels S, Davis M, Phillips AL, Meletiche D

      View abstract
    Health Care
  • Cardiovascular and economic outcomes after initiation of lipid-lowering therapy with atorvastatin vs simvastatin in an employed population

    Mayo Clin Proc. 2009 Dec;84(12):1065-72
    2009

    Simpson R Jr,  Signorovitch JBirnbaum HIvanova J, Connolly C, Kidolezi Y, Kuznik A

      View abstract
    Epidemiology & BiostatisticsHealth Care
  • Economic impact of multiple sclerosis disease-modifying drugs in an employed population: direct and indirect costs

    Curr Med Res Opin. 2009 Apr;25(4):869-77
    2009

    Birnbaum HGIvanova JI, Samuels S, Davis M, Cremieux PY, Phillips AL, Meletiche D

      View abstract
    Health Care
  • Asthma severity categorization using a claims-based algorithm or pulmonary function testing

    J Asthma. 2009 Feb;46(1):67-72
    2009

    Birnbaum HIvanova J, Yu A, Hsieh M, Seal B, Emani S, Rosiello R, Colice G

      View abstract
    Epidemiology & BiostatisticsHealth Care
  • Adherence to inhaled corticosteroid use and local adverse events in persistent asthma

    Am J Manag Care. 2008 Dec;14(12):801-9
    2008

    Ivanova JBirnbaum H, Hsieh M, Yu A, Seal B, van der Molen T, Emani S, Rosiello R, Colice G

      View abstract
    Epidemiology & BiostatisticsHealth Care
  • Health Care Costs of Adults Treated for Attention-Deficit, Hyperactivity Disorder Who Received Alternative Drug Therapies

    J Manag Care Pharm 2007 Sep;13(7):561-9
    2007

    Wu E, Birnbaum H, Zhang H, Ivanova J, Yang E, Mallet D

      View abstract
    Health Care
  • Prevalence, referral patterns, testing, and surgery in aortic valve disease: leaving women and elderly patients behind?

    J Heart Valve Dis 2007 Jul;16(4):362-9
    2007

    Bach D, Ivanova J, Birnbaum H, Fournier A, Tuttle E

      View abstract
    Epidemiology & BiostatisticsHealth Care
  • Economic evaluation of weekly epoetin alfa versus biweekly darbepoetin alfa for chemotherapy-induced anaemia: evidence from a 16-week randomised trial

    PharmacoEconomics. 2006;24(5):479-94.
    2006

    Reed SD, Radeva JI, Daniel DB, Mody SH, Forlenza JB, McKenzie RS, Schulman KA

      View abstract
    Health Care
  • Geographic variation in the prescription of schedule II opioid analgesics among outpatients in the United States

    Health Serv Res. 2006 Jun;41(3 Pt 1):837-55.
    2006

    Curtis LH, Stoddard J, Ivanova JI, Hutchison S, Dans PE, Wright A, Woosley RL, Schulman KA

      View abstract
    Health Care
  • Economic evaluation of valsartan in patients with chronic heart failure: results from Val-HeFT adapted to The Netherlands

    Journal of Medical Economics. 2006; 9:121-131.
    2006

    Boersma  C, Ivanova JI, Koopmanschap MA, Voors AA, Postma  MJ

      View abstract
    Health Care
  • National estimates of the use of hematopoietic stem-cell transplantation in children with cancer in the United States

    Bone Marrow Transplant. 2005;36:397-404.
    2005

    Ivanova JI, VanScoyoc E, Smith FO, Curtis LH, Breitfeld PP

      View abstract
    Health Care
  • Economic evaluation of everolimus vs. azathioprine at one year after de novo heart transplantation

    Clin Transplant. 2005 Feb;19(1):122-9.
    2005

    Ivanova JI, Reed SD, Kalo Z, Kauf TL, Cantu E 3rd, Cretin N, Schulman KA

      View abstract
    Health Care
  • Economic evaluation of zoledronic acid versus pamidronate for the prevention of skeletal-related events in metastatic breast cancer and multiple myeloma

    Am J Clin Oncol. 2005;28:8-16
    2005

    Reed SD, Ivanova JI, Glendenning GA, Coleman RE, Schulman KA

      View abstract
    Health Care
  • Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT)

    Am Heart J. 2005 Aug;150(2):323-9.
    2005

    Reed SD, Ivanova JI, Weinfurt KP, McMurray JJ, Pfeffer MA, Velazquez EJ, Allsbrook JS, Masselink LE, Sellers M, Califf RM, Schulman KA, VALIANT Investigators

      View abstract
    Health Care
  • Early hemoglobin response and alternative metrics of efficacy with erythropoietic agents for chemotherapy-related anemia

    Curr Med Res Opin. 2005;21:1527-1533.
    2005

    Reed SD, Ivanova JI, Daniel DB, Fastenau JM, Williams D, Schulman KA

      View abstract
    Health Care
  • State-mandated continuing medical education and the use of proven therapies in patients with an acute myocardial infarction

    J Am Coll Cardiol. 2004 Jul 7;44(1):192-8
    2004

    Patel MR, Meine TJ, Ivanova JI, Curtis L, Rao SV, Schulman KA, Jollis JG

      View abstract
    Health Care
  • Cost-effectiveness of zoledronic acid for the prevention of skeletal complications in patients with prostate cancer

    J Urol. 2004;171:1537-42
    2004

    Reed SD, Ivanova JI, Glendenning GA, Saad F, Schulman KA

      View abstract
    Health Care